DNA RNA and Cells

27 Sep 2016 Kite Pharma Announces Positive Topline KTE-C19 Data from ZUMA-1 Pivotal Trial in Patients with Aggressive Non-Hodgkin Lymphoma (NHL)
27 Sep 2016 MiNA Therapeutics Announces Presentation of Pre-Clinical Data Supporting On-Target Mechanism of Action of Clinical Candidate MTL-CEBPA
26 Sep 2016 Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metastatic Melanoma
26 Sep 2016 Abeona Therapeutics Enrolls First Patient in Phase 2 for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa
26 Sep 2016 Biogen Completes Rolling Submission of New Drug Application to FDA for Nusinersen as a Treatment for Spinal Muscular Atrophy
25 Sep 2016 Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1
22 Sep 2016 First Patient Enrolled in Toca 6, Tocagen's Trial for Metastatic Cancers Evaluating Intravenously Delivered Toca 511 Virus
22 Sep 2016 Mirna Therapeutics Halts Phase 1 Clinical Study of MRX34
22 Sep 2016 Akcea Announces Publication in The Lancet of Clinical Results with Lp(a)-Lowering Drugs Designed to Treat Cardiovascular Disease
20 Sep 2016 AmpliPhi Biosciences Provides Update on Phase 1 Trial in Chronic Rhinosinusitis Patients
19 Sep 2016 UK Regulatory Authority Approves Cynata GvHD Clinical Trial
19 Sep 2016 Adaptimmune Announces Strategic Manufacturing Agreement with PCT to Support Development of SPEAR® T-cell Therapies Towards Commercialization
19 Sep 2016 FDA grants accelerated approval to first drug for Duchenne muscular dystrophy
17 Sep 2016 Adverum Biotechnologies Presents Preclinical Data on Novel Gene Therapy Candidates for the Treatment of Wet AMD at The Retina Society 2016 Annual Meeting
14 Sep 2016 Asterias Biotherapeutics AST-OPC1 Treatment for Spinal Cord Injury Patients Shown to Help Patients Paralyzed from the Neck Down Regain Function in the Arms and Hands
14 Sep 2016 AmpliPhi Biosciences Announces Topline Results from Its Phase 1 Phage Therapy Trial Conducted in the United States
14 Sep 2016 Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
12 Sep 2016 AmpliPhi Biosciences’ Bacteriophage Cocktail Shown to Prevent C. difficile Biofilm Formation and Reduce Colonization
12 Sep 2016 Celgene Announces Interim Topline Data from Trial of Investigational Oral GED-0301 in Patients with Active Crohn’s Disease
12 Sep 2016 Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease
10 Sep 2016 CELYAD S.A.: Celyad completes the NKR-2 Phase I trial with successful safety follow-up of the fourth dose level
10 Sep 2016 Data presented today at EBMT symposium support Zalmoxis‘ innovative therapy potential in representing an efficacious and safe answer to a significant unmet clinical need for a life- threatening condition
09 Sep 2016 bluebird bio Opens Phase 3 Study of LentiGlobin™ Drug Product in Patients with Transfusion-Dependent Beta-Thalassemia
08 Sep 2016 JCAR014 Clinical Data Published in Science Translational Medicine: Patients with Advanced Lymphoma in Remission after T-cell Therapy
07 Sep 2016 Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AS1, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing